Fibrate (200 mg) CapsuleGeneric : Fenofibric Acid | ₹ 69.40
200mg
10 Capsules |
PO- The recommended dose is 48-145 mg/day.
Gastrointestinal: Inflammation of the lining of the stomach, abdominal pain, Constipation, flatulence, upset stomach, nausea and diarrhea.
Central Nervous System: Difficulty in sleeping, lack of energy and headache.
♦ Musculoskeletal: Back pain, leg pain, joint pain, burning feet, and body ache, muscle pain, (rhabdomyolysis).
Respiratory: Breathing problem and runny nose.
♦ Miscellaneous: Abnormal liver function and numbness in legs and paradoxical decreases in HDL level.
It comes as a tablet to take by mouth, once daily, with or without food.
Contraindicated in patients with hypersensitivity, liver or severe kidney dysfunction.
Caution needed in patients with history of preexisting gallbladder disease, during pregnancy and breastfeeding.
Follow the diet, exercise and weight loss program given to you by your healthcare provider.
Do not take more than the recommended dose without checking with your doctor.
Monitor liver function test (LFT) before starting therapy and at 12 week after starting and periodically thereafter.
Patient may develop with increased risk of muscular disease, kidney failure, kidney stones, gallbladder stones, and inflammation of pancreas. If it is so stop this medication.
Consultation with your doctor needed in the following conditions:muscle pain, tenderness or weakness.
Store at 25°C. Store it in an airtight container and keep away from children.
A: Fibrate (200 mg) is not a statin. It is a fibric acid derivative (fibrates) used in the treatment of hypertriglyceridemia and dyslipidemia(1✔ ✔Trusted Source
Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia
Go to source).
A: It is safe and effective to treat mixed dyslipidemia with Fibrate (200 mg) in combination with low to moderate dose statins(2✔ ✔Trusted Source
Fenofibric acid for hyperlipidemia
Go to source).
A: Fibrate (200 mg) is available in the form of a capsule, a long-acting capsule, and a tablet to be taken orally. Normally, it is taken once a day, with or without food(3✔ ✔Trusted Source
Fenofibrate
Go to source).
A: Myopathy is the most common toxicity associated with fenofibrate when combined with statin medications(4✔ ✔Trusted Source
Fenofibrate
Go to source).
A: Fenofibrate is not recommended for patients who have a history of fenofibrate hypersensitivity, liver disease, severe renal dysfunction, preexisting gallbladder disease, or who are breastfeeding(4✔ ✔Trusted Source
Fenofibrate
Go to source).
MediBot
